ES2007720A6 - Procedimiento de obtencion de una vacuna a base de flagelo bacterial. - Google Patents

Procedimiento de obtencion de una vacuna a base de flagelo bacterial.

Info

Publication number
ES2007720A6
ES2007720A6 ES8702709A ES8702709A ES2007720A6 ES 2007720 A6 ES2007720 A6 ES 2007720A6 ES 8702709 A ES8702709 A ES 8702709A ES 8702709 A ES8702709 A ES 8702709A ES 2007720 A6 ES2007720 A6 ES 2007720A6
Authority
ES
Spain
Prior art keywords
small
flagella
bacterial
vaccine
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8702709A
Other languages
English (en)
Inventor
Robert L Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of ES2007720A6 publication Critical patent/ES2007720A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE UNA VACUNA A BASE DE FLAGELO BACTERIAL, CARACTERIZADO PORQUE COMPRENDE: A) AISLAR FLAGELO DE UNA BACTERIA FLAGELADA PORAPLICACION DE UN ESFUERZO CORTANTE PARA ROMPER EL FLAGELO DE SUSCUERPOS CELULARES Y SEPARACION DEL FLAGELO DE LOS CUERPOS CELULARES POR CENTRIFUGADO; Y B) CONJUGAR QUIMICAMENTE DICHO FLAGELO A UN ANTIGENO, CON UN COMPUESTO RETICULANTE QUIMICO. LA VACUNA ES ESPECIALMENTE EFICAZ PARA VACUNAR UN HUMANO O UN ANIMAL CONTRA UN PEPTIDO U OTRO PEQUEÑO HAPTENO. LA VACUNA MEJORADA PROPORCIONA UNA INMUNO-RESPUESTA PROLONGADA Y POTENTE CONTRA EL PEPTIDO U OTRO PEQUEÑO HAPTENO.
ES8702709A 1986-09-22 1987-09-22 Procedimiento de obtencion de una vacuna a base de flagelo bacterial. Expired ES2007720A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90996486A 1986-09-22 1986-09-22
US7518787A 1987-07-16 1987-07-16

Publications (1)

Publication Number Publication Date
ES2007720A6 true ES2007720A6 (es) 1989-07-01

Family

ID=26756538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8702709A Expired ES2007720A6 (es) 1986-09-22 1987-09-22 Procedimiento de obtencion de una vacuna a base de flagelo bacterial.

Country Status (17)

Country Link
EP (1) EP0283505B1 (es)
JP (1) JPH01501064A (es)
KR (1) KR920002165B1 (es)
CN (1) CN1030019A (es)
AP (1) AP8700068A0 (es)
AT (1) ATE108067T1 (es)
BR (1) BR8707471A (es)
CA (1) CA1322721C (es)
DE (1) DE3750176T2 (es)
DK (1) DK272688A (es)
ES (1) ES2007720A6 (es)
FI (1) FI882397A0 (es)
GR (1) GR871460B (es)
IL (1) IL83953A (es)
NZ (2) NZ221868A (es)
PT (1) PT85760B (es)
WO (1) WO1988001873A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338618C (en) * 1987-11-03 1996-10-01 Noelene E. Byars Vaccine adjuvant
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
EP1278542A2 (en) 2000-05-05 2003-01-29 Cytos Biotechnology AG Molecular antigen arrays and vaccines
KR20020032772A (ko) * 2000-10-27 2002-05-04 김정우 살모넬라균에 대한 난황항체
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
AU2003246690B2 (en) 2002-07-17 2010-03-11 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
BR0312297A (pt) 2002-07-18 2005-04-12 Cytos Biotechnology Ag Conjugados veìculos de hapteno e seu uso
KR101070078B1 (ko) 2002-07-19 2011-10-04 노파르티스 파르마 아게 아밀로이드 베타1-6 항원 어레이를 포함하는 백신 조성물
WO2004022092A2 (en) * 2002-09-03 2004-03-18 Fondation Eurovacc Flagellin peptides as adjuvants for vaccines
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
US8420102B2 (en) 2006-03-07 2013-04-16 Vaxinnate Corporation Compositions that include hemagglutinin
US8728492B2 (en) * 2008-01-18 2014-05-20 Aeras Global Tb Vaccine Foundation Malaria vaccine compositions and constituents which elicit cell mediated immunity
CN104080475A (zh) 2008-04-18 2014-10-01 法克斯因内特公司 鞭毛蛋白的缺失突变体以及使用方法
US20120171239A1 (en) * 2009-09-03 2012-07-05 Mizel Steven B Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
CN101914144B (zh) * 2010-04-30 2013-01-09 浙江大学 金黄色葡萄球菌荚膜多糖和蛋白质偶联物及制备方法和用途
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US2979528A (en) * 1953-10-19 1961-04-11 Wyandotte Chemicals Corp Nitrogen-containing polyoxyalkylene detergent compositions
US3022335A (en) * 1955-03-30 1962-02-20 Wyandotte Chemicals Corp Surface active polyoxyalkylene compounds having a plurality of heteric polyoxypropylene-polyoxyethylene chains
US3036118A (en) * 1957-09-11 1962-05-22 Wyandotte Chemicals Corp Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
DE2860875D1 (en) * 1977-09-28 1981-10-15 Nat Res Dev Immunological preparations incorporating mhc antigens and their production
DE3063736D1 (en) * 1979-03-27 1983-07-21 Nat Res Dev Improvements in or relating to immunological preparations
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
FR2517967A1 (fr) * 1981-12-10 1983-06-17 Air Liquide Procede de production d'un vaccin biochimique contre les fievres a salmonelles
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)

Also Published As

Publication number Publication date
PT85760A (en) 1987-10-01
AU629103B2 (en) 1992-09-24
AU8023287A (en) 1988-04-07
EP0283505A1 (en) 1988-09-28
FI882397A (fi) 1988-05-20
DK272688A (da) 1988-07-12
GR871460B (en) 1988-03-21
AU613588B2 (en) 1991-08-08
CN1030019A (zh) 1989-01-04
DE3750176T2 (de) 1994-10-13
NZ221868A (en) 1991-03-26
CA1322721C (en) 1993-10-05
EP0283505A4 (en) 1989-11-07
FI882397A0 (fi) 1988-05-20
AU7113191A (en) 1991-07-11
AP8700068A0 (en) 1989-03-21
EP0283505B1 (en) 1994-07-06
JPH01501064A (ja) 1989-04-13
IL83953A0 (en) 1988-02-29
DK272688D0 (da) 1988-05-18
NZ236829A (en) 1993-07-27
KR880701560A (ko) 1988-11-03
DE3750176D1 (de) 1994-08-11
BR8707471A (pt) 1988-09-13
PT85760B (pt) 1990-08-31
IL83953A (en) 1992-05-25
KR920002165B1 (ko) 1992-03-19
WO1988001873A1 (en) 1988-03-24
ATE108067T1 (de) 1994-07-15

Similar Documents

Publication Publication Date Title
ES2007720A6 (es) Procedimiento de obtencion de una vacuna a base de flagelo bacterial.
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
GB9626484D0 (en) Helicobacter pylori antigenic protein preparation and immunoassays
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
GB2255093A (en) Hiv-1 core protein fragments
IL91007A0 (en) Synthetic vaccine against aids virus
TR199801722T2 (xx) Peptit imm�nojenler.
FR2677654B1 (fr) Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
GB2013691A (en) IgG Preparations
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
ES477212A1 (es) Un procedimiento para la preparacion de una enterotoxina.
GR3031889T3 (en) Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines.
ES8802118A1 (es) Un metodo para preparar un modulador inmune a base de un lipolisacarido bacteriano dextoxificado.
GB2250994B (en) Peptide fragments of hiv
NZ299579A (en) ue of hyperimmune milk to restore decreasing physiologic function
CA1263307C (en) PSEUDOMONAS NATIVE FLAGELLAR NATIVE FLAGELLAR ANTIGENS AND METHOD OF PRODUCING
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
NO892015L (no) Fremgangsmaate for fremstilling av et legemiddel.
HK1025220A1 (en) Novel saponin compositions and uses thereof
Petersen et al. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine
PL341541A1 (en) Isolated strains of staphyloccoccus aureus and vaccines prepared of them
TH6095EX (th) วัคซีนและวิธีเตรียม

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2007-09-22

FD1A Patent lapsed

Effective date: 20001204